 | • レポートコード：MRC2302A040P • 出版社/出版日：360iResearch / 2023年2月1日 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後3日） • 産業分類：食品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に1,112.53百万ドルであった世界のDFM（微生物の直接供給/直接添加型微生物）市場規模が、2022年に1,199.53百万ドルに達し、2027年には1,765.15百万ドルまで年平均7.99％で成長すると予測しています。当レポートは、DFM（微生物の直接供給/直接添加型微生物）の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、形態別（乾燥、液体）分析、家畜別（水生動物、家禽類、反芻動物、豚）分析、種類別（枯草菌、乳酸菌）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、ADISSEO、Alltech Inc.、American Biosystems, Inc.、Archer Daniels Midland Company、BASF SE (BASF Corporation)、BENTOLI INC、Bio-Vet、Biomin Holding GmbH、Cargill Inc.、Chr. Hansen Holding A/S、DSM N.V.、E.I. Dupont De Nemours and Company、Evonik Industries AG、Kemin Industries, Inc.、Koninklijke DSM N.V.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のDFM（微生物の直接供給/直接添加型微生物）市場規模：形態別 - 乾燥DFMの市場規模 - 液体DFMの市場規模 ・世界のDFM（微生物の直接供給/直接添加型微生物）市場規模：家畜別 - 家禽類の市場規模 - 反芻動物の市場規模 - 豚の市場規模 ・世界のDFM（微生物の直接供給/直接添加型微生物）市場規模：種類別 - 枯草菌の市場規模 - 乳酸菌の市場規模 ・世界のDFM（微生物の直接供給/直接添加型微生物）市場規模：地域別 - 南北アメリカのDFM（微生物の直接供給/直接添加型微生物）市場規模 アメリカのDFM（微生物の直接供給/直接添加型微生物）市場規模 カナダのDFM（微生物の直接供給/直接添加型微生物）市場規模 ブラジルのDFM（微生物の直接供給/直接添加型微生物）市場規模 ... - アジア太平洋のDFM（微生物の直接供給/直接添加型微生物）市場規模 日本のDFM（微生物の直接供給/直接添加型微生物）市場規模 中国のDFM（微生物の直接供給/直接添加型微生物）市場規模 インドのDFM（微生物の直接供給/直接添加型微生物）市場規模 韓国のDFM（微生物の直接供給/直接添加型微生物）市場規模 台湾のDFM（微生物の直接供給/直接添加型微生物）市場規模 ... - ヨーロッパ/中東/アフリカのDFM（微生物の直接供給/直接添加型微生物）市場規模 イギリスのDFM（微生物の直接供給/直接添加型微生物）市場規模 ドイツのDFM（微生物の直接供給/直接添加型微生物）市場規模 インドのDFM（微生物の直接供給/直接添加型微生物）市場規模 フランスのDFM（微生物の直接供給/直接添加型微生物）市場規模 ロシアのDFM（微生物の直接供給/直接添加型微生物）市場規模 ... - その他地域のDFM（微生物の直接供給/直接添加型微生物）市場規模 ・競争状況 ・企業情報 |
The Global Direct-fed Microbials Market size was estimated at USD 1,112.53 million in 2021 and expected to reach USD 1,199.53 million in 2022, and is projected to grow at a CAGR 7.99% to reach USD 1,765.15 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Direct-fed Microbials to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Form, the market was studied across Dry and Liquid.
Based on Livestock, the market was studied across Aquatic Animals, Poultry, Ruminants, and Swine.
Based on Type, the market was studied across Bacillus subtilis and Lactic Acid Bacteria. The Bacillus subtilis is further studied across Bifidobacteria, Lactobacilli, and Streptococcus Thermophilus.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Direct-fed Microbials market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Direct-fed Microbials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Direct-fed Microbials Market, including ADISSEO, Alltech Inc., American Biosystems, Inc., Archer Daniels Midland Company, BASF SE (BASF Corporation), BENTOLI INC, Bio-Vet, Biomin Holding GmbH, Cargill Inc., Chr. Hansen Holding A/S, DSM N.V., E.I. Dupont De Nemours and Company, Evonik Industries AG, Kemin Industries, Inc., Koninklijke DSM N.V., Lallemand, Inc., Micron Bio-Systems, Novozymes, Novus International, Inc., Nutraferma, Inc., Protexin, ProviCo Pty Ltd, Strong Microbials INC., and The Fertrell Company.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Direct-fed Microbials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Direct-fed Microbials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Direct-fed Microbials Market?
4. What is the competitive strategic window for opportunities in the Global Direct-fed Microbials Market?
5. What are the technology trends and regulatory frameworks in the Global Direct-fed Microbials Market?
6. What is the market share of the leading vendors in the Global Direct-fed Microbials Market?
7. What modes and strategic moves are considered suitable for entering the Global Direct-fed Microbials Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about animal health
5.1.1.2. Rise in global meat and milk consumption
5.1.1.3. Increased demand for quality animal products
5.1.1.4. Increase in demand for animal protein
5.1.2. Restraints
5.1.2.1. Varying regulations about the consumption of bacteria in food and feed
5.1.3. Opportunities
5.1.3.1. Prohibition on the usage of antibiotic growth promoters (AGP)
5.1.3.2. Health benefits for livestock due to rising animal health concerns
5.1.4. Challenges
5.1.4.1. Increasing cost of production and operations
5.2. Cumulative Impact of COVID-19
6. Direct-fed Microbials Market, by Form
6.1. Introduction
6.2. Dry
6.3. Liquid
7. Direct-fed Microbials Market, by Livestock
7.1. Introduction
7.2. Aquatic Animals
7.3. Poultry
7.4. Ruminants
7.5. Swine
8. Direct-fed Microbials Market, by Type
8.1. Introduction
8.2. Bacillus subtilis
8.3.1. Bifidobacteria
8.3.2. Lactobacilli
8.3.3. Streptococcus Thermophilus
8.3. Lactic Acid Bacteria
9. Americas Direct-fed Microbials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Direct-fed Microbials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Direct-fed Microbials Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. ADISSEO
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Alltech Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. American Biosystems, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Archer Daniels Midland Company
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. BASF SE (BASF Corporation)
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. BENTOLI INC
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Bio-Vet
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Biomin Holding GmbH
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Cargill Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Chr. Hansen Holding A/S
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. DSM N.V.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. E.I. Dupont De Nemours and Company
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Evonik Industries AG
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Kemin Industries, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Koninklijke DSM N.V.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Lallemand, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Micron Bio-Systems
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Novozymes
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Novus International, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Nutraferma, Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Protexin
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. ProviCo Pty Ltd
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Strong Microbials INC.
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. The Fertrell Company
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing